MIRA INFORM REPORT
|
Report Date : |
09.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
DINCO LTD. |
|
|
|
|
Registered Office : |
22 Keren Hayesod Street, Industrial Zone, Tirat
Carmel 39026 |
|
|
|
|
Country : |
Israel |
|
|
|
|
Date of Incorporation : |
09.12.1968 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Importers, marketers, installers and service providers of X-Ray, scientific
and other medical imaging equipment, especially in the NDT sector, as well as
for industrial uses |
|
|
|
|
No. of Employees
: |
28 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 150,000. |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Israel |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
DINCO LTD.
Telephone 972
4 813 15 15
Fax 972 4 813 15 16
22 Keren Hayesod Street
Industrial Zone
TIRAT CARMEL-39026-ISRAEL
A private limited company, incorporated as per file No. 51-050826-0 on the
09.12.1968.
Authorized share capital NIS 2.00, divided into -
20,000
ordinary shares of NIS 0.0001 each,
of which 2,100
shares amounting to NIS 0.21 were issued.
(Note: The currency in share capital was
originally in Old Israeli Shekel whose nominal value was 1 thousandth of
the current New Israeli Shekel (NIS), converted in 1986).
1. Yair Zeiger, 50%,
2. Mrs. Sara Zeiger, wife of Yair, 50%.
1. Yair Zeiger, General Manager,
2. Zeev Zeiger (son of Yair Zeiger).
Importers, marketers, installers and service providers of X-Ray,
scientific and other medical imaging equipment, especially in the NDT sector,
as well as for industrial uses.
Sales are to medical centers, hospitals, HMOs, private medical imaging
centers, universities, companies, etc.
Among clientele: CLALIT HEALTH SERVICES, MACCABI HEALTH SERVICES, Israel
Defense Force, RAFAEL ADVANCED DEFENSE SYSTEMS, STRAUSS, HADASSA HOSPITAL,
SCHNEIDER CHILDREN'S MEDICAL CENTER, Israel Police, MAZOR LACHAI VETERINARY
HOSPITAL, SOROKA MEDICAL CENTER, and many more.
Local sole representative of:
SHIMADZU, FUJIFILM (medical equipment), both of Japan,
METTLER TOLEDO, of USA,
DEKOM, of Germany.
Operating from owned premises, on a built area of 4,000 sq. meters (a 5
story building)), in 22 Keren Hayesod Street, Industrial Zone, Tirat Carmel.
Having 28 employees (same as in 2011).
Current stock valued at US$ 1,700,000 (was valued at US$ 1,500,000 in
2011).
Owned property (5 floors in 22 Keren Hayesod Street, Tirat Hacarmel),
where subject is operating from, is valued at US$ 4,000,000.
There are 5 charges for unlimited amounts, as well as 4 charges for the total
sum of NIS 417,776.00 registered on the company’s assets (financial assets,
vehicles and a medical system), in favor of Bank Leumi Le'Israel Ltd. and its
leasing company (last 4 charges placed November – December 2011).
2007 sales claimed to be US$ 8,000,000.
2008 sales claimed to be US$ 8,000,000.
2009 sales claimed to be US$ 8,000,000.
2010 sales claimed to be US$ 8,000,000.
2011 sales claimed to be US$ 8,000,000.
D.N.R. IMAGING
SYSTEMS LTD., non active, Yair Zeiger holds 27% of company; updated data not
forthcoming).
Bank Leumi
Le'Israel Ltd., Main Haifa Branch (No. 876), Haifa, account No. 71300/70.
A check with the Central Banks' database did not reveal any negative
information regarding subject's a/m account.
Nothing
unfavorable learned.
Subject is a long
established company, well known in its field.
Israel is
considered one of the leading countries in the world in terms of investment in the
Life Science and Biotechnology industry. In 2008 Israel was ranked 4th in investments in Biotechnology/GDP, while being among the leaders in the areas
of investments and patents in Medical Device and
Bio-Pharma fields.
During 2008 total of
US$ 87 million were given to local Life Science firms by the Chief Scientist
Office.
Local consumption
market for medical and aesthetic electronic equipment and instrumentation was
estimated at over US$ 1 billion (sales by local manufacturers and from import),
based on the Ministry of Industry & Trade research in 2009.
There are some 160
local companies operating in the medical equipment field. According to the
Ministry of Industry & Trade survey in 2008.
Good for trade
engagements.
Maximum unsecure credit recommended US$ 150,000.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.50.57 |
|
UK Pound |
1 |
Rs.79.57 |
|
Euro |
1 |
Rs.66.50 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.